#USA #New York #Securities Fraud #Pomerantz Law Firm #Neogen Corporation

On July 7, 2025, Pomerantz LLP announced that it is investigating potential claims concerning Neogen Corporation, a company listed on NASDAQ under the ticker symbol NEOG. This investigation aims to uncover whether Neogen, alongside its officers and directors, has been involved in securities fraud or other illicit business practices that could affect current and future investors. Recent disclosures by Neogen have raised concerns, prompting the firm’s inquiry. On June 4, 2025, the company revealed that its expected financial results for the fourth quarter of fiscal 2025 would significantly differ from prior guidance. Specifically, Neogen projected an EBITDA margin in the high teens, a stark drop from 22% in the preceding quarter. This downturn was attributed to 'elevated inventory write-offs,' which alarmed investors. Following this announcement, Neogen’s stock price plummeted by $1.04, representing a significant 17.3% decrease, closing at $4.96 per share on the same day. The implications of this decline could be severe, and investors holding shares of Neogen Corporation are being urged to reach out to attorney Danielle Peyton at Pomerantz for more details on the matter. Established in New York, Chicago, Los Angeles, London, and Paris, the Pomerantz Firm is renowned for its expertise in corporate and securities class litigation. The firm has a rich history, with roots tracing back over 80 years, founded by the esteemed Abraham L. Pomerantz. Known as the dean of class action law, he was instrumental in establishing securities class action litigation. Today, Pomerantz continues to uphold this tradition by advocating for victims of securities fraud and corporate misconduct. The firm has achieved multiple multimillion-dollar settlements on behalf of investors affected by such malpractices. Investors believing they have been wronged are encouraged to contact Pomerantz for assistance. As the investigation unfolds, the potential ramifications for Neogen Corporation and its stock price will depend heavily on the findings of the Pomerantz investigation, making it essential for investors to stay informed. To learn more about the class action and how to participate, individuals interested are advised to follow up with the provided contact information.